Monopar Therapeutics Inc. (MNPR)

NASDAQ

$74.15

$+2.45

(+3.44%)

Pre-Market

Monopar Therapeutics Inc. (MNPR) Live Price Chart

Last updated: ⁦2026-10-21 08:14:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Monopar Therapeutics Inc. (MNPR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $74.15, with a market capitalization of $479.72M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $50.07 to $124.82. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$479.72M
Open	$72.20
Day's High	$240.00
Day's Low	$1.37
Previous Close	$71.47
Volume	73.19K
Average Volume	197.86K
P/E Ratio	--
52-Week High	$124.82
52-Week Low	$50.07
Dividend Yield	--
Earnings Date	--

Monopar Therapeutics Inc. (MNPR) Pre-Market Stock Price

Monopar Therapeutics Inc. (MNPR) is trading at $72.00 in pre-market trading as of 2026-10-20 23:33:00, up 0.74% ($0.53) from the previous close of $71.47

Pre-market trading shows how investors are pricing MNPR before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Monopar Therapeutics Inc. (MNPR) 7-Day Stock Price Change

Over the past seven days, Monopar Therapeutics Inc. (MNPR) moved from $77.05 to $74.15, representing a decline of 3.77% ($2.90).

The stock traded between $68.81 and $79.59 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 140.16 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

MNPR 52-Week Price Position

Position in Range: 32.2%

52W Low$50.07

52W High$124.82

MNPR is currently trading at $74.15, placing it 32.2% of the way from its 52-week low of $50.07 to its 52-week high of $124.82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Monopar Therapeutics Inc. (MNPR)?

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.

Monopar Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	22
Exchange	NASDAQ
Company Website	https://www.monopartx.com

How to Buy Monopar Therapeutics Inc. (MNPR) Stock on MEXC

Eligible investors can buy real shares of Monopar Therapeutics Inc. (MNPR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MNPR and Place Your Order

Open the RealStocks trading page and search for MNPR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Monopar Therapeutics Inc. (MNPR) stock price today?

Monopar Therapeutics Inc. (MNPR) is currently trading at $ 74.15, up 3.74% ($2.68) from the previous close of $ 71.47. Intraday prices update in real time during regular trading hours.

2.Is MNPR stock going up or down today?

As of 2026-10-20 23:33:00, MNPR is trading at $ 74.15, up 3.74% ($2.68) from its previous close of $ 71.47. The stock has traded between $ 1.37 and $ 240.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is MNPR pre-market price?

As of 2026-10-20 23:33:00, MNPR is trading at $ 72.00 in pre-market trading, up 0.74% ($0.53) from the previous close of $ 71.47. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MNPR after-hours price?

As of 2026-10-20 23:33:00, MNPR is trading at $ 74.69 in after-hours trading, up 4.50% ($3.22) from the regular-session close of $ 71.47. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MNPR stock trading now?

MNPR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MNPR sit relative to its 52-week high and low?

Over the past 52 weeks, MNPR has traded between a low of $ 50.07 and a high of $ 124.82. At $ 74.15, the stock is positioned 32.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Monopar Therapeutics Inc. in?

Monopar Therapeutics Inc. (MNPR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Monopar Therapeutics Inc.'s market capitalization and where is it listed?

Monopar Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 479.72M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MNPR valued in terms of P/E ratio and EPS?

MNPR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.66. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Monopar Therapeutics Inc. pay a dividend?

Monopar Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.